04:12 AM EDT, 09/23/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) could consider directly listing its shares on the New York Stock Exchange, potentially replacing its American depositary receipts, London's Financial Times reported Wednesday, citing Chief Executive Officer Mike Doustdar. The Danish drugmaker is currently not pursuing such a listing, but Doustdar said he sees "some advantages" and is open to further discussions on the idea, according to the report. Doustdar added that the company is holding talks with US investors amid growing interest from investors outside Scandinavia.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.